期刊文献+

丹参川芎注射液联合低分子肝素钙围手术期预防下肢深静脉血栓形成的临床观察 被引量:8

Clinical Observation on Salvia ChuanXiong Injection Combined With Low Molecular Weight Heparin Calcium in Preventing From Deep Vein Thrombosis of Lower Limbs During the Perioperative Period
下载PDF
导出
摘要 目的评价丹参川芎注射液联合低分子肝素钙预防下肢血管围手术期深静脉血栓(DVT)形成的疗效。方法将50例62条下肢随机分成两组,A组31例于围手术期应用丹参川芎注射液10ml联合低分子肝素钙0.3~0.4ml,B组31例于围手术期只应用低分子肝素钙0.3~0.4ml。术后第4~7天常规行双下肢深静脉彩超检查,了解深静脉血栓发生情况。结果 A组无一例发生DVT,B组3例(9.6%)发生DVT,两组比较有显著差异('P<0.05')。结论丹参川芎注射液联合低分子肝素钙能有效预防下肢血管围手术期深静脉血栓形成。 Objective To evaluate effects of Salvia Chuanxiong injection combined with low molecular heparin calcium in preventing deep vein thrombosis( DVT) of lower limbs during the perioperative period. Methods 50 cases with 62 limbs were randomly divided into 2 groups. A group of 31 cases in perioperative were applied Salvia Chuanxiong injection 10ml and low molecular heparin calcium 0. 3 ~ 0. 4ml. Group B of 31 cases in perioperative were used only low molecular heparin calcium 0. 3 ~ 0. 4ml. Varicose veins color dopplar ultrasound of double limbs would be examined to understand the deep vein thrombosis after 4 ~ 7 days. Results No case in A group was happened DVT and 3 cases( 9. 6%) in B group occurred DVT,2 groups of comparisons had significantly difference( P < 0. 05). Conclusion Salvia Chuanxiong injection joint low molecular heparin calcium could effectively prevent the lower limbs perioperative blood vessels of deep vein thrombosis.
作者 邵启峰 杨平
出处 《光明中医》 2014年第1期148-149,共2页 GUANGMING JOURNAL OF CHINESE MEDICINE
关键词 丹参川芎注射液 低分子肝素钙 下肢血管 深静脉血栓形成 Salvia Chuanxiong injection low molecular heparin calcium lower limb blood vessels deep vein thrombosis
  • 相关文献

参考文献2

二级参考文献27

  • 1翟任友.深静脉血栓的诊断和介入治疗[C].第五界全国介入放射学学术交流大会论文集,2002:73-76.
  • 2Kearon C,Ginsberg JS,Douketis J,et al.Management of suspected deep venous thrombosis in outpatients by using clinical assessment and D-dimer testing Ann Intern Med,2001,135(2):108.
  • 3Harenberg J.Fixed-dose versus adjusted-dose low molecular weight heparin for the initial treatment of patients with deep venous,thrombosis.Curr Opin Pulm Med,2002,8(5):383.
  • 4Wells PS,Forster AJ.Thrombolysis in deep vein thrombosis:is there still an indication? Thromst Hacmost,2001,86(1):499.
  • 5Forster AJ,Wells PS.The rationale and evidence for the treatment of lower-extremity deep venous thrombosis with thrombolytic agents.Curr Opin Hematol,2002,9(5):437.
  • 6Rhodes JM,Cho JS,GloviczkiP,et al.Thrombolysis for experimental deep venous thromosis maintains valvular competence and vasoreactivity.J Vasc Surg,2000,31(6):1193.
  • 7Rutherford RB.Vascular surgery.5th ed.Copyrights:Health Sciences Asia,Elsevier Science,2002,1959.
  • 8Aburahma AF,Perkins SE,Wulu JT,et al.Iliofemoarl deep vein thrombosis:conventional therapy versus lysis and percuataneous transduminal angioplasty and stenting.Ann Surg,2001,233(6):752.
  • 9O Sullivan GJ,Semba CP,Bittner CA,et al.Endovascular management of iliac vein compression(May-Thurner)syndrome.J vasc interv Radiol,2000,11(7):823.
  • 10Lamont JP,Pearl GJ,Patetsios P,et al.Prospective evaluation of endoluminal venous stents in the treatment of the May-Thurner Syndrome.Am Vasc Surg,2002,16(1):61.

共引文献54

同被引文献67

引证文献8

二级引证文献22

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部